SCHEMBL4197942

SCHEMBL4197942

Cn1c(=O)n(C)c2cc(Cl)ccc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
HSD17B10 Q99714 3/20 0.53
HPGD P15428 3/20 0.53
HTT P42858 3/20 0.53
ALDH1A1 P00352 7/20 0.52
MAPT P10636 3/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.52
PKM P14618 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
BRD4 O60885 2/20 0.52
BRPF1 P55201 2/20 0.52
KDM4E B2RXH2 2/20 0.52
TP53 P04637 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
DRD2 P14416 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16997507 0.81 LMNA (0.46) LMNAL3MBTL1HSD17B10HPGDHTT
SCHEMBL14615686 0.81 MAPK14 (0.46) LMNAL3MBTL1HSD17B10HPGDHTT
SCHEMBL14615685 0.81 HPD (0.51) LMNAL3MBTL1HSD17B10HPGDHTT
SCHEMBL7642570 0.80 XBP1 (0.50) LMNAL3MBTL1HSD17B10HPGDHTT
SCHEMBL6953268 0.80 LMNA (0.51) LMNAL3MBTL1HSD17B10HPGDHTT
SCHEMBL11462221 0.78 PSMB8 (0.52) LMNAL3MBTL1HSD17B10HPGDALDH1A1
SCHEMBL13178918 0.76 LMNA (0.55) LMNAL3MBTL1HPGDHTTALDH1A1
SCHEMBL435035 0.76 KMT2A (0.54) LMNAHSD17B10HTTALDH1A1KMT2A
SCHEMBL15426207 0.75 ALDH1A1 (0.73) LMNAL3MBTL1HSD17B10HPGDHTT
SCHEMBL14615582 0.75 LMNA (0.53) LMNAL3MBTL1HSD17B10HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1601335-B1 MEANS AND METHOD FOR THE SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBRES WELLA AG (DE) 2008-03-19 EP claimed
US-20060162096-A1 Means and method for the simultaneous bleaching and dyeing of keratin fibres HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2006-07-27 US claimed
EP-1601335-A1 MEANS AND METHOD FOR THE SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-12-07 EP claimed
WO-2004078152-A1 MEANS AND METHOD FOR THE SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO claimed
WO-2014036022-A1 QUINAZOLINONE COMPOUNDS AND DERIVATIVES THEREOF AMGEN INC. (US) 2014-03-06 WO disclosed
US-7790726-B2 Monocyclic and bicyclic compounds and methods of use CHEMOCENTRYX, INC. (US) 2010-09-07 US disclosed
US-20090130165-A1 MIF Inhibitors CORTICAL PTY LTD 2009-05-21 US disclosed
US-7429274-B2 Agent and method for the oxidative coloring of keratin fibers WELLA AG (DE) 2008-09-30 US disclosed
US-7326254-B2 Means and method for the simultaneous bleaching and dyeing of keratin fibres WELLA AG (DE) 2008-02-05 US disclosed
US-7244278-B2 Agent and method for oxidative coloring of keratin fibers WELLA AG (DE) 2007-07-17 US disclosed
US-20070079452-A1 Agent and method for the oxidative coloring of keratin fibers Wella GmbH (DE) 2007-04-12 US disclosed
US-20070067927-A1 Agent and method for oxidative coloring of keratin fibers HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2007-03-29 US disclosed
US-20060162096-A1 Means and method for the simultaneous bleaching and dyeing of keratin fibres HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060162096-A1 Means and method for the simultaneous bleaching and dyeing of keratin fibres KRT18, GPX4, NOX4 LMNA 984/4885L3MBTL1 4866/4885HSD17B10 1345/4885
US-20070067927-A1 Agent and method for oxidative coloring of keratin fibers KRT18, KIT, AOC1 LMNA 90/4885L3MBTL1 4883/4885HSD17B10 1907/4885
US-20090130165-A1 MIF Inhibitors MIF, MMP12, IL4 LMNA 4039/4885L3MBTL1 1815/4885HSD17B10 2179/4885
US-20070079452-A1 Agent and method for the oxidative coloring of keratin fibers KRT18, KIT, CKMT1A; CKMT1B LMNA 103/4885L3MBTL1 4883/4885HSD17B10 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.